First clinical trial to investigate the efficacy and safety of combined SGLT2 inhibitor and GLP-1R agonist therapy in patients with T2DM, suggesting additive or synergistic effects on weight loss
J AGAR: It is completely life-changing to take a bite of these triggering foods and just be, like, enjoy it, say, yep
To explore this possibility, researchers conducted a double-blind, placebo-controlled clinical trial
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
The magnitude of incremental benefit and the probability of achieving 2 additional percentage points of weight loss varied across treatment strategies and baseline regimens
Patients on tirzepatide who experience fatigue during titration Patients with low or borderline B12 levels Patients who want fewer injections during their weight-management protocol Contraindications and cautions